Monday, February 11, 2013

A possible snag in the clinical study

I already have an update. Our oncologist, Dr. Flaig, called this evening to say that there's a chance Marshall won't qualify for the clinical study of GTX-758 because of his weight. He says that one of the requirements to be enrolled in this study is a body mass index of 35 or less and he looked at Marshall's records and said it was going to be very very close.

So I found a BMI calculator online and the way we figure it, Marshall's BMI right at this moment is 34.8. So we have determined that we are going to really watch our diets between now and March 1st to be sure that at least he will pass that hurdle. Dr. Flaig said that he thinks this drug is going to be the drug of the future in the fight against prostate cancer so we are very excited about it! (Talk about an incentive to diet and exercise....)



- Posted using BlogPress from my iPad

No comments:

Post a Comment